Jazz Pharmaceuticals (JAZZ) FCF Margin (2010 - 2026)
Jazz Pharmaceuticals' (JAZZ) quarterly FCF Margin came in at 30.97% in Q1 2026, down 1691.0% year-on-year from 1.95% in Q1 2025, and down 68.07% quarter-over-quarter from 96.99% in Q4 2025.
Jazz Pharmaceuticals (JAZZ) FCF Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' FCF Margin history runs 17 years deep, the most recent figure standing at 30.97% for Q1 2026.
- On a quarterly basis, FCF Margin fell 1691.0% year-over-year to 30.97% in Q1 2026; TTM through Mar 2026 was 27.0%, a 1051.0% decrease from a year earlier, with the FY2025 full-year figure at 30.39%, down 298.0% from the prior year.
- FCF Margin eased to 30.97% in Q1 2026 per JAZZ's latest filing, from 96.99% in the prior quarter.
- Across five years, FCF Margin topped out at 96.99% in Q4 2025 and bottomed at 33.98% in Q3 2025.
- The 5-year median for FCF Margin is 31.5% (2023), against an average of 31.37%.
- Biggest YoY gain for FCF Margin was 6158 bps in 2025; the steepest drop was 7075 bps in 2025.
- Year by year, FCF Margin stood at 34.73% in 2022, then plunged by 48 bps to 17.91% in 2023, then soared by 98 bps to 35.41% in 2024, then jumped by 174 bps to 96.99% in 2025, then sank by 68 bps to 30.97% in 2026.
- Per Business Quant, the three latest JAZZ FCF Margin figures stand at 30.97% (Q1 2026), 96.99% (Q4 2025), and 33.98% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn | 30.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.97% |
| Dec 31, 2025 | 96.99% |
| Sep 30, 2025 | -33.98% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | 47.87% |
| Dec 31, 2024 | 35.41% |
| Sep 30, 2024 | 36.77% |
| Jun 30, 2024 | 31.40% |
| Mar 31, 2024 | 29.17% |
| Dec 31, 2023 | 17.91% |
| Sep 30, 2023 | 31.50% |
| Jun 30, 2023 | 30.05% |
| Mar 31, 2023 | 35.49% |
| Dec 31, 2022 | 34.73% |
| Sep 30, 2022 | 42.38% |
| Jun 30, 2022 | 32.34% |
| Mar 31, 2022 | 25.80% |
| Dec 31, 2021 | 21.88% |
| Sep 30, 2021 | 30.61% |
| Jun 30, 2021 | 5.50% |